Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone helps human pancreatic cells increase insulin release.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Finasteride and metformin both help treat PCOS, but using them together works best.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Trilostane treatment successfully restored hair growth in a dog with alopecia X.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride increases hair count and improves hair growth with low risk of side effects.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

The document concludes that effectively managing PCOS requires a multifaceted approach.